- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection ; volume:29 ; number:1 ; day:4 ; month:1 ; year:2022 ; pages:1-50 ; date:12.2022
Journal of biomedical science ; 29, Heft 1 (4.1.2022), 1-50, 12.2022
- Urheber
-
Hwang, Yu-Chyi
Lu, Ruei-Min
Su, Shih-Chieh
Chiang, Pao-Yin
Ko, Shih-Han
Ke, Feng-Yi
Liang, Kang-Hao
Hsieh, Tzung-Yang
Wu, Han-Chung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-021-00784-w
- URN
-
urn:nbn:de:101:1-2022042313215868263797
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hwang, Yu-Chyi
- Lu, Ruei-Min
- Su, Shih-Chieh
- Chiang, Pao-Yin
- Ko, Shih-Han
- Ke, Feng-Yi
- Liang, Kang-Hao
- Hsieh, Tzung-Yang
- Wu, Han-Chung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
Generation and Characterization of Monoclonal Antibodies directed against SARS-CoV-2
ELISA detection of SARS-CoV-2 antibodies in saliva
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
Monoclonal antibodies
Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
Generation and Characterization of Monoclonal Antibodies directed against SARS-CoV-2
ELISA detection of SARS-CoV-2 antibodies in saliva
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
Monoclonal antibodies
Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
Generation and Characterization of Monoclonal Antibodies directed against SARS-CoV-2
ELISA detection of SARS-CoV-2 antibodies in saliva
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
Monoclonal antibodies
Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants